ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,608,933 | +151.7% | 707,028 | +125.8% | 0.04% | +150.0% |
Q1 2023 | $1,036,487 | -53.5% | 313,138 | -45.5% | 0.01% | -60.0% |
Q4 2022 | $2,231,225 | -33.0% | 575,058 | -79.0% | 0.04% | -7.9% |
Q3 2022 | $3,331,328 | +6698.6% | 2,739,104 | +10859.9% | 0.04% | +3700.0% |
Q2 2022 | $49,000 | -97.9% | 24,992 | -98.1% | 0.00% | -96.6% |
Q1 2022 | $2,382,000 | +235.5% | 1,301,638 | +158.3% | 0.03% | +480.0% |
Q4 2021 | $710,000 | – | 503,889 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |